Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Ceribell, Inc. ( (CBLL) ) is now available.
On July 7, 2025, Ceribell, Inc. announced it filed complaints against Natus Medical Incorporated with the U.S. International Trade Commission and the U.S. District Court for the District of Delaware, alleging patent infringement and unfair competition related to its EEG headband and electrode design. Ceribell seeks to protect its intellectual property and maintain fair competition, requesting an investigation and exclusion order to prevent the importation of infringing Natus products into the U.S., highlighting its commitment to innovation in point-of-care EEG technology.
The most recent analyst rating on (CBLL) stock is a Buy with a $31.00 price target. To see the full list of analyst forecasts on Ceribell, Inc. stock, see the CBLL Stock Forecast page.
Spark’s Take on CBLL Stock
According to Spark, TipRanks’ AI Analyst, CBLL is a Neutral.
Ceribell, Inc. receives a moderate score of 59. The company’s robust revenue growth and strategic advancements are tempered by significant profitability challenges and cash management issues. Technical indicators favor short-term momentum, but the lack of valuation clarity and increased expenses present risks.
To see Spark’s full report on CBLL stock, click here.
More about Ceribell, Inc.
Ceribell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform designed for acute care settings, utilizing portable hardware and AI-powered algorithms for rapid diagnosis and monitoring. The Ceribell System is FDA-cleared for indicating suspected seizure activity and is used in intensive care units and emergency rooms across the U.S. Ceribell is headquartered in Sunnyvale, California.
Average Trading Volume: 399,631
Technical Sentiment Signal: Hold
Current Market Cap: $684.2M
See more insights into CBLL stock on TipRanks’ Stock Analysis page.